The Japanese Aggrenox (Extended-Release Dipyridamole plus Aspirin) Stroke Prevention versus Aspirin Programme (JASAP) Study: A Randomized, Double-Blind, Controlled Trial

Publisher: Karger

E-ISSN: 1421-9786|31|6|601-613

ISSN: 1015-9770

Source: Cerebrovascular Diseases, Vol.31, Iss.6, 2011-04, pp. : 601-613

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content